Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MPI | P34949 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13706155 | 0.90 | ALOX5 (0.38) | CYP11B1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13706282 | 0.89 | PIM3 (0.44) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL13706098 | 0.88 | HSD17B1 (0.40) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL24178521 | 0.88 | CYP11B1 (0.42) | CYP11B1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL16303040 | 0.86 | CYP11B1 (0.43) | CYP11B1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL18907475 | 0.86 | ALDH1A1 (0.39) | CYP11B1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13706287 | 0.86 | MCL1 (0.44) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL13520281 | 0.86 | GSTP1 (0.44) | CYP11B1PTGS2GPR84PIM3HSD17B1 | |
| SCHEMBL18907601 | 0.84 | GPR3 (0.44) | CYP11B1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13706188 | 0.84 | GPR3 (0.38) | MEN1KMT2AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OXER1, L1CAM, RPL41 | CYP11B1 675/4885MEN1 2284/4885KMT2A 4444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.